OBJECTIVES: To test whether parathyroid hormone (PTH) might be related to the development of atherosclerosis in postmenopausal women, we measured serum levels of PTH, the carotid intima-media thickness (IMT), and other clinical and biochemical parameters. METHODS: One hundred and seven postmenopausal women were recruited for this study. The serum level of PTH was measured by immunoradiometric assay, and carotid IMT was measured with high resolution B-mode ultrasonography. RESULTS: On the basis of bivariate correlation analyses or unpaired t-tests, the body mass index (BMI), waist circumference, estimated glomerular filtration rate, and 25-hydroxyvitamin D were not associated with carotid IMT. In contrast, age (r = 0.414, p < 0.001), serum...
Introduction: Thyroid hormones affect the cardiovascular system, but the precise mechanisms of their...
textabstractBACKGROUND AND PURPOSE: Observational data suggest that hormone replacement t...
Background: The mechanisms by which menopause may influence the systemic subclinical atherosclerosis...
Objective: There is increasing evidence of a direct association between normal androgen levels and r...
Objectives: Both cardiovascular calcification and atherosclerosis are strong predictors of cardiovas...
Context: Growing evidence demonstrates that hyperparathyroidism is associated with an increased risk...
CONTEXT AND OBJECTIVES: Controversy exists regarding the relationship between atherosclerosis and os...
Objective : To assess the 2-year effects of postmenopausal hormone replacement therapy (HRT) on prog...
Studies examining the relation between endogenous postmenopausal hormone levels and cardiovascular d...
OBJECTIVES: Cardiovascular disease (CVD) is a leading cause of death in postmenopausal women. Elevat...
Copyright © 2012 Kelly D. Lloyd et al. This is an open access article distributed under the Creative...
Purpose: To investigate the effect of 18 monthsâ parathyroid hormone 1â84 (PTH 1â84) treatment on se...
OBJECTIVE: The aim of this study was to assess the correlation between bone mineral density (BMD), a...
Objective: The physiological role of parathormone (PTH) in the maintenance of bone mass in humans ha...
Background Primary hyperparathyroidism (PHPT) is associated with hypertension, coronary atherosclero...
Introduction: Thyroid hormones affect the cardiovascular system, but the precise mechanisms of their...
textabstractBACKGROUND AND PURPOSE: Observational data suggest that hormone replacement t...
Background: The mechanisms by which menopause may influence the systemic subclinical atherosclerosis...
Objective: There is increasing evidence of a direct association between normal androgen levels and r...
Objectives: Both cardiovascular calcification and atherosclerosis are strong predictors of cardiovas...
Context: Growing evidence demonstrates that hyperparathyroidism is associated with an increased risk...
CONTEXT AND OBJECTIVES: Controversy exists regarding the relationship between atherosclerosis and os...
Objective : To assess the 2-year effects of postmenopausal hormone replacement therapy (HRT) on prog...
Studies examining the relation between endogenous postmenopausal hormone levels and cardiovascular d...
OBJECTIVES: Cardiovascular disease (CVD) is a leading cause of death in postmenopausal women. Elevat...
Copyright © 2012 Kelly D. Lloyd et al. This is an open access article distributed under the Creative...
Purpose: To investigate the effect of 18 monthsâ parathyroid hormone 1â84 (PTH 1â84) treatment on se...
OBJECTIVE: The aim of this study was to assess the correlation between bone mineral density (BMD), a...
Objective: The physiological role of parathormone (PTH) in the maintenance of bone mass in humans ha...
Background Primary hyperparathyroidism (PHPT) is associated with hypertension, coronary atherosclero...
Introduction: Thyroid hormones affect the cardiovascular system, but the precise mechanisms of their...
textabstractBACKGROUND AND PURPOSE: Observational data suggest that hormone replacement t...
Background: The mechanisms by which menopause may influence the systemic subclinical atherosclerosis...